Product NDC: | 62756-513 |
Proprietary Name: | LEVETIRACETAM |
Non Proprietary Name: | LEVETIRACETAM |
Active Ingredient(s): | 100 mg/mL & nbsp; LEVETIRACETAM |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62756-513 |
Labeler Name: | Sun Pharmaceutical Industries Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090754 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100617 |
Package NDC: | 62756-513-40 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (62756-513-40) > 5 mL in 1 VIAL, SINGLE-USE |
NDC Code | 62756-513-40 |
Proprietary Name | LEVETIRACETAM |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (62756-513-40) > 5 mL in 1 VIAL, SINGLE-USE |
Product NDC | 62756-513 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LEVETIRACETAM |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100617 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharmaceutical Industries Limited |
Substance Name | LEVETIRACETAM |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |